Cargando…
A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects
BACKGROUND: Teduglutide, a recombinant analog of human glucagon-like peptide (GLP)-2, is a novel therapy recently approved for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. Previous studies assessing the effect of GLP-2 on gastric emptying in huma...
Autores principales: | Berg, Jolene Kay, Kim, Eric H, Li, Benjamin, Joelsson, Bo, Youssef, Nader N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928318/ https://www.ncbi.nlm.nih.gov/pubmed/24517114 http://dx.doi.org/10.1186/1471-230X-14-25 |
Ejemplares similares
-
Teduglutide for short bowel syndrome
Publicado: (2020) -
Acute Epigallocatechin 3 Gallate (EGCG) Supplementation Delays Gastric Emptying in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
por: Fernandes, Renata C., et al.
Publicado: (2018) -
Gastric emptying and duodenal motility upon intake of a liquid meal with monosodium glutamate in healthy subjects
por: Teramoto, Hidemi, et al.
Publicado: (2014) -
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide
por: Fujioka, Ken, et al.
Publicado: (2016) -
Teduglutide in amyloidosis‐associated intestinal failure
por: Luhn, Clara, et al.
Publicado: (2023)